Compare ADMA Biologics Inc (ADMA) vs Appian Corp (APPN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs Appian Corp — how do they compare? ADMA Biologics Inc trades at $9.06 (market cap $2.13B), while Appian Corp trades at $24.27 (market cap $1.81B). The key difference: ADMA Biologics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| ADMA | APPN | |
|---|---|---|
Market Cap | $2.13B | $1.81B |
Sector | Health | Technology |
52-Week High | $20.38 | $45.64 |
52-Week Low | $7.60 | $18.72 |
Enterprise Value | $2.20B | $1.90B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About Appian Corp
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →
